检索结果 - Lara Fuentes
- Showing 1 - 1 results of 1
-
1
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial 由 Rafael Romaguera, Pablo Salinas, Josep Gómez‐Lara, Salvatore Brugaletta, Antonio Gómez‐Menchero, Miguel Romero, Sergio García‐Blas, Raymundo Ocaranza, Pascual Bordes, Marcelo Jiménez Kockar, Neus Salvatella, Víctor Alfonso Jiménez Díaz, Mar Alameda, Ramiro Trillo, Dae Hyun Lee, Pedro Martín, María López-Benito, Alfonso Freites, Virginia Pascual‐Tejerina, Felipe Hernández, Bruno García del Blanco, Mohsen Mohandes, Francisco Bosa, Eduardo Pinar, Gerard Roura, Josep Comín‐Colet, Antonio Fernández-Ortı́z, Carlos Macaya, Xavier Rosselló, Manel Sabaté, Stuart Pocock, Joan Antoni Gómez‐Hospital, Carlos Salazar, Luis Ortega‐Paz, José M. de la Torre Hernández, Armando Pérez de Prado, Juan Sanchís, Soledad Ojeda, José Luis Ferreiro, Montserrat Gracida, Lara Fuentes, Luis Teruel, Guillem Muntané‐Carol, Rocío Castillo-Poyo, Pilar Jiménez‐Quevedo, Ángel Cequier
出版 2021Artigo
相关主题
Cardiology
Clinical endpoint
Confidence interval
Coronary artery disease
Diabetes mellitus
Drug-eluting stent
Endocrinology
Hazard ratio
Internal medicine
Medicine
Myocardial infarction
Percutaneous coronary intervention
Randomized controlled trial
Revascularization
Stent
Surgery
Target lesion
Zotarolimus